Cargando…

Beyond FDG: novel PET tracers for cancer imaging

Despite the excellent clinical performance of fluorodeoxyglucose (FDG) as a cancer-imaging agent for positron emission tomography (PET), false positive and false negative results can be problematic in some clinical settings. Radiopharmaceutical development has recently focussed on the search for new...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hicks, Rodney J
Formato:	Texto
Lenguaje:	English
Publicado:	e-MED 2003
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434524/ https://www.ncbi.nlm.nih.gov/pubmed/18211857 http://dx.doi.org/10.1102/1470-7330.2003.0032

Ejemplares similares

PET tracer development—a tale of mice and men
por: Hicks, Rodney J, et al.
Publicado: (2006)

Imaging with non-FDG PET tracers: outlook for current clinical applications
por: Lopci, Egesta, et al.
Publicado: (2010)

Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation
por: Toner, Yohana C., et al.
Publicado: (2022)

How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology
por: Lasocki, Arian, et al.
Publicado: (2019)

PET Tracers for Clinical Imaging of Breast Cancer
por: Peñuelas, Iván, et al.
Publicado: (2012)

How We Read Oncologic FDG PET/CT
por: Hofman, Michael S., et al.
Publicado: (2016)

Plasma radio-metabolite analysis of PET tracers for dynamic PET imaging: TLC and autoradiography
por: Li, Fiona, et al.
Publicado: (2020)

Overview of early response assessment in lymphoma with FDG-PET
por: MacManus, Michael P, et al.
Publicado: (2007)

Application of PET Tracers in Molecular Imaging for Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2020)

Multi-contrast attenuation map synthesis for PET/MR scanners: assessment on FDG and Florbetapir PET tracers
por: Burgos, Ninon, et al.
Publicado: (2015)

PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers
por: Saric, Petar, et al.
Publicado: (2021)

Advanced Tracers in PET Imaging of Cardiovascular Disease
por: Li, Yesen, et al.
Publicado: (2014)

White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism
por: Hofman, Michael S, et al.
Publicado: (2011)

High Correlation of Static First-Minute-Frame (FMF) PET Imaging after (18)F-Labeled Amyloid Tracer Injection with [(18)F]FDG PET Imaging
por: Seiffert, Alexander P., et al.
Publicado: (2021)

Emerging PET Tracers in Cardiac Molecular Imaging
por: Singh, Shashi Bhushan, et al.
Publicado: (2023)

PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score
por: Dondi, Francesco, et al.
Publicado: (2023)

PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

Protocols for Dual Tracer PET/SPECT Preclinical Imaging
por: Blower, Julia E., et al.
Publicado: (2020)

Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
por: Kolinger, Guilherme D., et al.
Publicado: (2022)

Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes
por: Emsen, Berivan, et al.
Publicado: (2020)

A Dual Tracer (18)F-FCH/(18)F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model
por: Fu, Yilong, et al.
Publicado: (2016)

Potential PET tracers for imaging of tumor-associated macrophages
por: Fernandes, Bruna, et al.
Publicado: (2022)

Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
por: Helgebostad, Rasmus, et al.
Publicado: (2022)

Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
por: Huang, Yuan, et al.
Publicado: (2021)

PET Tracers for Imaging Cardiac Function in Cardio-oncology
por: Kelly, James M., et al.
Publicado: (2022)

Breast PET/MRI Hybrid Imaging and Targeted Tracers
por: Romeo, Valeria, et al.
Publicado: (2022)

Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
por: Hofman, MS, et al.
Publicado: (2015)

Dual Tracer PET Imaging (68Ga-DOTATATE and 18F-FDG) Features in Pulmonary Carcinoid: Correlation with Tumor Proliferation Index
por: Bhatkar, Dhiraj, et al.
Publicado: (2017)

The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients
por: Koleva-Kolarova, R G, et al.
Publicado: (2015)

Novel Thienopyrimidine-Based PET Tracers for P2Y(12) Receptor Imaging in the Brain
por: van der Wildt, Berend, et al.
Publicado: (2021)

Evaluation of radiofluorinated carboximidamides as potential IDO-targeted PET tracers for cancer imaging
por: Huang, Xuan, et al.
Publicado: (2017)

CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer
por: Erdmann, Sarah, et al.
Publicado: (2019)

The utility of (18) F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification
por: Cochet, Alexandre, et al.
Publicado: (2014)

Utility of [(68)Ga]FAPI-04 and [(18)F]FDG dual-tracer PET/CT in the initial evaluation of gastric cancer
por: Miao, Ying, et al.
Publicado: (2022)

Investigation of 6-[(18)F]-Fluoromaltose as a Novel PET Tracer for Imaging Bacterial Infection
por: Gowrishankar, Gayatri, et al.
Publicado: (2014)

A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis
por: Gormsen, Lars C., et al.
Publicado: (2016)

Simultaneous in vivo imaging with PET and SPECT tracers using a Compton-PET hybrid camera
por: Uenomachi, Mizuki, et al.
Publicado: (2021)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1h6gv032a5kp6om9asogfbgfv1